Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.03 +0.33 (+8.78%)
As of: Sep 29, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Non-Current Assets (2020 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) posted Non-Current Assets of $609.21 million for Q2 2026, down 14.8% from $715.2 million a year earlier and down 3.3% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Recursion Pharmaceuticals' Non-Current Assets came in at $661.29 million, down 9.9% from FY2024.

  • Annual Non-Current Assets shows a five-year compound annual growth rate of 83.1% (FY2020 to FY2025).
  • In prior years, Recursion Pharmaceuticals' Non-Current Assets was $734.33 million in FY2024 (+240.7%), $215.56 million in FY2023 (+64.0%), $131.47 million in FY2022 (+73.8%) and $75.63 million in FY2021 (+135.2%).
  • The Q2 2026 figure stands as the lowest quarterly Non-Current Assets since Q3 2024.
  • On a year-over-year basis, Non-Current Assets has declined in each of the last three quarters, with growth averaging 101.0% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2024, with growth of 240.7%; the weakest was Q2 2026, with a decline of 14.8%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $629.97 million (Q1 2026), $661.29 million (Q4 2025) and $685.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn 609.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 609.21 Mn
Mar 31, 2026 629.97 Mn
Dec 31, 2025 661.29 Mn
Sep 30, 2025 685.42 Mn
Jun 30, 2025 715.20 Mn
Mar 31, 2025 721.09 Mn
Dec 31, 2024 734.33 Mn
Sep 30, 2024 252.33 Mn
Jun 30, 2024 253.49 Mn
Mar 31, 2024 214.23 Mn
Dec 31, 2023 215.56 Mn
Sep 30, 2023 220.30 Mn
Jun 30, 2023 235.68 Mn
Mar 31, 2023 135.24 Mn
Dec 31, 2022 131.47 Mn
Sep 30, 2022 129.92 Mn
Jun 30, 2022 126.52 Mn
Mar 31, 2022 114.86 Mn
Dec 31, 2021 75.63 Mn
Sep 30, 2021 57.74 Mn
API Access

Recursion Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=RXRX&period=max&api_key=YOUR_API_KEY